Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Icotinib Cream in Mild to Moderate Psoriasis
NCT03222622Phase 2Terminated
- Sponsor
- Betta Pharmaceuticals
- Start
- Nov 2017
- Primary completion
- Aug 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of icotinib in plaque psoriasis, sponsored by Betta Pharmaceuticals. Started Nov 2017; status: terminated.
02
Drugs
icotinib
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT03222622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03222622.